NFA
JAZZ icon

Nationwide Fund Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Nationwide Fund Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-24,500
Closed -$3.58M – 1051
2017
Q3 		$3.58M Buy
24,500
+3,500
+17% +$529K 0.01% 1171
2017
Q2 		$3.27M Buy
21,000
+9,750
+87% +$1.49M 0.01% 1215
2017
Q1 		$1.63M Sell
11,250
-11,250
-50% -$1.47M 0.01% 1500
2016
Q4 		$2.45M Sell
22,500
-65,720
-74% -$7.32M 0.01% 1320
2016
Q3 		$10.7M Sell
88,220
-58,810
-40% -$7.93M 0.04% 579
2016
Q2 		$20.8M Buy
147,030
+126,432
+614% +$18.6M 0.09% 261
2016
Q1 		$2.69M Buy
20,598
+4,266
+26% +$531K 0.01% 1213
2015
Q4 		$2.3M Sell
16,332
-8,126
-33% -$1.13M 0.01% 1304
2015
Q3 		$3.25M Sell
24,458
-24,481
-50% -$4.22M 0.01% 1131
2015
Q2 		$8.62M Sell
48,939
-31,960
-40% -$5.74M 0.04% 657
2015
Q1 		$14M Buy
80,899
+22,942
+40% +$3.94M 0.06% 437
2014
Q4 		$9.49M Buy
57,957
+2,557
+5% +$424K 0.04% 580
2014
Q3 		$8.89M Buy
55,400
+5,900
+12% +$907K 0.04% 621
2014
Q2 		$7.28M Sell
49,500
-33,416
-40% -$4.63M 0.03% 760
2014
Q1 		$11.5M Buy
82,916
+48,690
+142% +$7.33M 0.05% 442
2013
Q4 		$4.33M Sell
34,226
-16,310
-32% -$1.69M 0.02% 1030
2013
Q3 		$4.65M Buy
50,536
+10,920
+28% +$881K 0.02% 948
2013
Q2 		$2.72M Buy
+39,616
New +$2.42M 0.01% 1127

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SIG
Senator Investment Group New York $2.74B AUM 55.95% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Nationwide Fund Advisors's JAZZ Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2017, closing a stake of 24,500 shares — an estimated $3.58M sold.

Nationwide Fund Advisors first reported a position in JAZZ in Q2 2013 and held it in 18 quarters. The position peaked at $20.8M in Q2 2016. 323 funds tracked by Wall St. Rank hold JAZZ as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Jazz Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 24,500 Jazz Pharmaceuticals shares in Q4 2017, an estimated $3.58M.
  • Nationwide Fund Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Jazz Pharmaceuticals position peaked at $20.8M in Q2 2016.
  • 323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.